Extracorporeal membrane oxygenation bridging to lung transplant complicated by heparin-induced thrombocytopenia

Experimental and Clinical Transplantation

Volumn 8, Issue 4, 2010, Pages 329-332

  Dolch, Michael E ^a   Frey, Lorenz ^a   Hatz, Rudolf ^a   Überfuhr, Peter A ^a   Beiras Fernandez, Andres ^a   Behr, Jürgen ^a   Irlbeck, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acute respiratory distress syndrome; Anticoagulation; Argatroban; Complications; Lung assist

Indexed keywords

ARGATROBAN; HEPARIN; THROMBOPLASTIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULATION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CASE REPORT; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTRACORPOREAL OXYGENATION; GRAFT FAILURE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LIVER FAILURE; LUNG ASPERGILLOSIS; LUNG TRANSPLANTATION; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PARTIAL THROMBOPLASTIN TIME; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE HEMORRHAGE; RESPIRATORY FAILURE; THROMBOCYTE COUNT; THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; EXTRACORPOREAL MEMBRANE OXYGENATION; FATAL OUTCOME; HEPARIN; HUMANS; LUNG TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; PIPECOLIC ACIDS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; THROMBOCYTOPENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650555941     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280(2):159-165.
2. Jackson A, Cropper J, Pye R, Junius F, Malouf M, Glanville A. Use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature. J Heart Lung Transplant. 2008;27(3):348-352.
3. Nand S, Wong W, Yuen B, Yetter A, Schmulbach E, Gross Fisher S. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol. 1997;56(1):12-16.
4. Erratum in: Am J Hematol. 1998;58(3):253.
5. Keeling D, Davidson S, Watson H; Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. The management of heparin-induced thrombocytopenia. Br J Haematol. 2006;133(3):259-269. Erratum in: Br J Haematol. 2006;134(3):351.
6. Bauer C, Vichova Z, Ffrench P, Hercule C, Jegaden O, Bastien O, et al. Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism. Anesth Analg. 2008;106(4):1101-1103.
7. Balasubramanian SK, Tiruvoipati R, Chatterjee S, Sosnowski A, Firmin RK. Extracorporeal membrane oxygenation with lepirudin anticoagulation for Wegener's granulomatosis with heparin-induced thrombocytopenia. ASAIO J. 2005;51(4):477-479.
8. Dager WE, Gosselin RC, Yoshikawa R, Owings JT. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation. Ann Pharmacother. 2004;38(4):598-601.
9. Beiderlinden M, Treschan T, Görlinger K, Peters J. Argatroban in extracorporeal membrane oxygenation. Artif Organs. 2007;31(6):461-465.
10. Cornell T, Wyrick P, Fleming G, Pasko D, Han Y, Custer J, et al. A case series describing the use of argatroban in patients on extracorporeal circulation. ASAIO J. 2007;53(4):460-463.
11. Chan M, Malynn E, Shaz B, Uhl L. Utility of consecutive repeat HIT ELISA testing for heparin-induced trombocytopenia. Am C Hematol.2008;83:212-217.
12. Koster A, Sänger S, Hansen R, Sodian R, Mertzlufft F, Harke C, et al. Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices. ASAIO J. 2000;46(3):319-322.
13. Swan SK, Hursting MJ. The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction. Pharmacotherapy. 2000;20(3):318-329.
14. Beiderlinden M, Treschan TA, Görlinger K, Peters J. Argatroban anticoagulation in critically ill patients. Ann Pharmacother. 2007;41(5):749-754. Erratum in: Ann Pharmacother. 2007;41(7):1320.
15. Heil S. Heparin-induced thrombocytopenia type II with thrombosis in an intensive care patient: therapy management using the direct thrombin inhibitor argatroban [in German]. Anaesthesist. 2009;58(11):1119-1122.
16. Müller T, Philipp A, Luchner A, Karagiannidis C, Bein T, Hilker M, et al. A new miniaturized system for extracorporeal membrane oxygenation in adult respiratory failure. Crit Care. 2009;13(6):R205.
17. Koster A, Loebe M, Sodian R, Potapov EV, Hansen R, Müller J, et al. Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devices. J Thorac Cardiovasc Surg. 2001;121(2):331-335.